Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells

We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunology 1991-08, Vol.3 (8), p.761-767
Hauptverfasser: Kannagi, Mari, Harada, Shinji, Maruyama, Ikuro, Inoko, Hidetoshi, Igarashi, Hisanaga, Kuwashima, Gorou, Sato, Shigeru, Morita, Michio, Kidokoro, Minoru, Sugimoto, Masanobu, Funahashi, Shin-ichi, Osame, Mitsuhiro, Shida, Hisatoshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 767
container_issue 8
container_start_page 761
container_title International immunology
container_volume 3
creator Kannagi, Mari
Harada, Shinji
Maruyama, Ikuro
Inoko, Hidetoshi
Igarashi, Hisanaga
Kuwashima, Gorou
Sato, Shigeru
Morita, Michio
Kidokoro, Minoru
Sugimoto, Masanobu
Funahashi, Shin-ichi
Osame, Mitsuhiro
Shida, Hisatoshi
description We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an asymptomatic HTLV-l-carrier, by repeated stimulation with autologous HTLV-I-Infected T cells In vitro. CTL derived from the patient with HAM/TSP expressed CD8 antigen, and their function was restricted by HLA-A2. They showed cytotoxic effects predominantly against the target cells expressing HTLV-I p40tax among the autologous B cell lines Infected with vaccinia recombinants containing various HTLV-I genes which served as targets. These data are consistent with the previously reported findings that fresh PBL of HAM/TSP patients contain p40tax-specific CTL activity. Furthermore, CTL derived from the patient with Sjögren syndrome without neurological involvement also demonstrated cytotoxicity predominantly to p40tax. The cytotoxicity to the target cells experimentally expressing p40tax was blocked by unlabeled HTLV-I-infected cells possessing HLA-A2. HTLV-l-specific cytotoxicity was also Inhibited by unlabeled B cells bearing p40tax. Thus, HTLV-I p40tax-specific cytotoxicity is mediated by the major CTL population activated by native HTLV-I antigens in patients with HAM/TSP or Sjögren syndrome. In contrast to the CTL of these patients, CTL similarly Induced from the asymptomatic HTLV-l-carrier, which were highly cytotoxic to autologous HTLV-l-infected T cells, did not show significant levels of cytotoxicity to autologous B cells expressing p40tax. These CTL possessed CD4 antigen. It was concluded that the predominant CTL population activated by HTLV-I stimulation differs in phenotype and antigen-specificity among HTLV-I seropositive individuals, and that these differences in CTL response may play a role in determining the susceptibility of the host to various HTLV-I related disorders.
doi_str_mv 10.1093/intimm/3.8.761
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72107903</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72107903</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-bc4ac5db1531533999eb1146c99eedc3e9d89aaf480e52c8f04ad849f68071253</originalsourceid><addsrcrecordid>eNpFUU2LFDEQDaKs4-rVm5CTKNKzSac_kuMyq9sDI64wyuIlpJPqMe50MiZp2fkz_laz9qBQUEW9V6-Kegi9pGRJiWAX1iU7jhdsyZdtQx-hBa0aUpSsbR-jBRE1Kzht-VP0LMYfhBBWCnaGzqigtK7qBfp9E8D40TrlEg6g_c7ZZL3DfsDfp1E5vMUa9nu8h-kORqvwLxumiNPxAHiN33Tbzddi_RYfbvEOHOBD8GbSKeL-eJpfXfF3WB-TT_7e6pNcxMbmbQkMVjtlXUx4ViqsG-b-X9pz9GRQ-wgvTvkcffnwfrvqis2n6_XqclPosiGp6HWldG16WrMcTAgBPc2P0LkAoxkIw4VSQ8UJ1KXmA6mU4ZUYGk5aWtbsHL2edfP9PyeISY42PlygHPgpyrakpBWEZeJyJurgYwwwyEOwowpHSYl8METOhkgmucyG5IFXJ-WpH8H8p88OZLyYcRsT3P-DVbiTTcvaWna33-THbnXTXYnP8pr9Aflil-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72107903</pqid></control><display><type>article</type><title>Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Kannagi, Mari ; Harada, Shinji ; Maruyama, Ikuro ; Inoko, Hidetoshi ; Igarashi, Hisanaga ; Kuwashima, Gorou ; Sato, Shigeru ; Morita, Michio ; Kidokoro, Minoru ; Sugimoto, Masanobu ; Funahashi, Shin-ichi ; Osame, Mitsuhiro ; Shida, Hisatoshi</creator><creatorcontrib>Kannagi, Mari ; Harada, Shinji ; Maruyama, Ikuro ; Inoko, Hidetoshi ; Igarashi, Hisanaga ; Kuwashima, Gorou ; Sato, Shigeru ; Morita, Michio ; Kidokoro, Minoru ; Sugimoto, Masanobu ; Funahashi, Shin-ichi ; Osame, Mitsuhiro ; Shida, Hisatoshi</creatorcontrib><description>We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an asymptomatic HTLV-l-carrier, by repeated stimulation with autologous HTLV-I-Infected T cells In vitro. CTL derived from the patient with HAM/TSP expressed CD8 antigen, and their function was restricted by HLA-A2. They showed cytotoxic effects predominantly against the target cells expressing HTLV-I p40tax among the autologous B cell lines Infected with vaccinia recombinants containing various HTLV-I genes which served as targets. These data are consistent with the previously reported findings that fresh PBL of HAM/TSP patients contain p40tax-specific CTL activity. Furthermore, CTL derived from the patient with Sjögren syndrome without neurological involvement also demonstrated cytotoxicity predominantly to p40tax. The cytotoxicity to the target cells experimentally expressing p40tax was blocked by unlabeled HTLV-I-infected cells possessing HLA-A2. HTLV-l-specific cytotoxicity was also Inhibited by unlabeled B cells bearing p40tax. Thus, HTLV-I p40tax-specific cytotoxicity is mediated by the major CTL population activated by native HTLV-I antigens in patients with HAM/TSP or Sjögren syndrome. In contrast to the CTL of these patients, CTL similarly Induced from the asymptomatic HTLV-l-carrier, which were highly cytotoxic to autologous HTLV-l-infected T cells, did not show significant levels of cytotoxicity to autologous B cells expressing p40tax. These CTL possessed CD4 antigen. It was concluded that the predominant CTL population activated by HTLV-I stimulation differs in phenotype and antigen-specificity among HTLV-I seropositive individuals, and that these differences in CTL response may play a role in determining the susceptibility of the host to various HTLV-I related disorders.</description><identifier>ISSN: 0953-8178</identifier><identifier>EISSN: 1460-2377</identifier><identifier>DOI: 10.1093/intimm/3.8.761</identifier><identifier>PMID: 1911545</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adult ; AIDS/HIV ; B-Lymphocytes - immunology ; CD8 Antigens - analysis ; Cell Line ; class I major histocompatibility complex ; Female ; Gene Products, tax - immunology ; HLA-A2 Antigen - immunology ; HTLV-I Infections - immunology ; HTLV-I-associated myelopathy ; Humans ; p40tax ; Paraparesis, Tropical Spastic - immunology ; Phenotype ; recombinant vaccinia virus ; T-Lymphocytes, Cytotoxic - immunology</subject><ispartof>International immunology, 1991-08, Vol.3 (8), p.761-767</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c260t-bc4ac5db1531533999eb1146c99eedc3e9d89aaf480e52c8f04ad849f68071253</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1911545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kannagi, Mari</creatorcontrib><creatorcontrib>Harada, Shinji</creatorcontrib><creatorcontrib>Maruyama, Ikuro</creatorcontrib><creatorcontrib>Inoko, Hidetoshi</creatorcontrib><creatorcontrib>Igarashi, Hisanaga</creatorcontrib><creatorcontrib>Kuwashima, Gorou</creatorcontrib><creatorcontrib>Sato, Shigeru</creatorcontrib><creatorcontrib>Morita, Michio</creatorcontrib><creatorcontrib>Kidokoro, Minoru</creatorcontrib><creatorcontrib>Sugimoto, Masanobu</creatorcontrib><creatorcontrib>Funahashi, Shin-ichi</creatorcontrib><creatorcontrib>Osame, Mitsuhiro</creatorcontrib><creatorcontrib>Shida, Hisatoshi</creatorcontrib><title>Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells</title><title>International immunology</title><addtitle>Int Immunol</addtitle><description>We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an asymptomatic HTLV-l-carrier, by repeated stimulation with autologous HTLV-I-Infected T cells In vitro. CTL derived from the patient with HAM/TSP expressed CD8 antigen, and their function was restricted by HLA-A2. They showed cytotoxic effects predominantly against the target cells expressing HTLV-I p40tax among the autologous B cell lines Infected with vaccinia recombinants containing various HTLV-I genes which served as targets. These data are consistent with the previously reported findings that fresh PBL of HAM/TSP patients contain p40tax-specific CTL activity. Furthermore, CTL derived from the patient with Sjögren syndrome without neurological involvement also demonstrated cytotoxicity predominantly to p40tax. The cytotoxicity to the target cells experimentally expressing p40tax was blocked by unlabeled HTLV-I-infected cells possessing HLA-A2. HTLV-l-specific cytotoxicity was also Inhibited by unlabeled B cells bearing p40tax. Thus, HTLV-I p40tax-specific cytotoxicity is mediated by the major CTL population activated by native HTLV-I antigens in patients with HAM/TSP or Sjögren syndrome. In contrast to the CTL of these patients, CTL similarly Induced from the asymptomatic HTLV-l-carrier, which were highly cytotoxic to autologous HTLV-l-infected T cells, did not show significant levels of cytotoxicity to autologous B cells expressing p40tax. These CTL possessed CD4 antigen. It was concluded that the predominant CTL population activated by HTLV-I stimulation differs in phenotype and antigen-specificity among HTLV-I seropositive individuals, and that these differences in CTL response may play a role in determining the susceptibility of the host to various HTLV-I related disorders.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>B-Lymphocytes - immunology</subject><subject>CD8 Antigens - analysis</subject><subject>Cell Line</subject><subject>class I major histocompatibility complex</subject><subject>Female</subject><subject>Gene Products, tax - immunology</subject><subject>HLA-A2 Antigen - immunology</subject><subject>HTLV-I Infections - immunology</subject><subject>HTLV-I-associated myelopathy</subject><subject>Humans</subject><subject>p40tax</subject><subject>Paraparesis, Tropical Spastic - immunology</subject><subject>Phenotype</subject><subject>recombinant vaccinia virus</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><issn>0953-8178</issn><issn>1460-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFUU2LFDEQDaKs4-rVm5CTKNKzSac_kuMyq9sDI64wyuIlpJPqMe50MiZp2fkz_laz9qBQUEW9V6-Kegi9pGRJiWAX1iU7jhdsyZdtQx-hBa0aUpSsbR-jBRE1Kzht-VP0LMYfhBBWCnaGzqigtK7qBfp9E8D40TrlEg6g_c7ZZL3DfsDfp1E5vMUa9nu8h-kORqvwLxumiNPxAHiN33Tbzddi_RYfbvEOHOBD8GbSKeL-eJpfXfF3WB-TT_7e6pNcxMbmbQkMVjtlXUx4ViqsG-b-X9pz9GRQ-wgvTvkcffnwfrvqis2n6_XqclPosiGp6HWldG16WrMcTAgBPc2P0LkAoxkIw4VSQ8UJ1KXmA6mU4ZUYGk5aWtbsHL2edfP9PyeISY42PlygHPgpyrakpBWEZeJyJurgYwwwyEOwowpHSYl8METOhkgmucyG5IFXJ-WpH8H8p88OZLyYcRsT3P-DVbiTTcvaWna33-THbnXTXYnP8pr9Aflil-o</recordid><startdate>19910801</startdate><enddate>19910801</enddate><creator>Kannagi, Mari</creator><creator>Harada, Shinji</creator><creator>Maruyama, Ikuro</creator><creator>Inoko, Hidetoshi</creator><creator>Igarashi, Hisanaga</creator><creator>Kuwashima, Gorou</creator><creator>Sato, Shigeru</creator><creator>Morita, Michio</creator><creator>Kidokoro, Minoru</creator><creator>Sugimoto, Masanobu</creator><creator>Funahashi, Shin-ichi</creator><creator>Osame, Mitsuhiro</creator><creator>Shida, Hisatoshi</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910801</creationdate><title>Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells</title><author>Kannagi, Mari ; Harada, Shinji ; Maruyama, Ikuro ; Inoko, Hidetoshi ; Igarashi, Hisanaga ; Kuwashima, Gorou ; Sato, Shigeru ; Morita, Michio ; Kidokoro, Minoru ; Sugimoto, Masanobu ; Funahashi, Shin-ichi ; Osame, Mitsuhiro ; Shida, Hisatoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-bc4ac5db1531533999eb1146c99eedc3e9d89aaf480e52c8f04ad849f68071253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>B-Lymphocytes - immunology</topic><topic>CD8 Antigens - analysis</topic><topic>Cell Line</topic><topic>class I major histocompatibility complex</topic><topic>Female</topic><topic>Gene Products, tax - immunology</topic><topic>HLA-A2 Antigen - immunology</topic><topic>HTLV-I Infections - immunology</topic><topic>HTLV-I-associated myelopathy</topic><topic>Humans</topic><topic>p40tax</topic><topic>Paraparesis, Tropical Spastic - immunology</topic><topic>Phenotype</topic><topic>recombinant vaccinia virus</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kannagi, Mari</creatorcontrib><creatorcontrib>Harada, Shinji</creatorcontrib><creatorcontrib>Maruyama, Ikuro</creatorcontrib><creatorcontrib>Inoko, Hidetoshi</creatorcontrib><creatorcontrib>Igarashi, Hisanaga</creatorcontrib><creatorcontrib>Kuwashima, Gorou</creatorcontrib><creatorcontrib>Sato, Shigeru</creatorcontrib><creatorcontrib>Morita, Michio</creatorcontrib><creatorcontrib>Kidokoro, Minoru</creatorcontrib><creatorcontrib>Sugimoto, Masanobu</creatorcontrib><creatorcontrib>Funahashi, Shin-ichi</creatorcontrib><creatorcontrib>Osame, Mitsuhiro</creatorcontrib><creatorcontrib>Shida, Hisatoshi</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kannagi, Mari</au><au>Harada, Shinji</au><au>Maruyama, Ikuro</au><au>Inoko, Hidetoshi</au><au>Igarashi, Hisanaga</au><au>Kuwashima, Gorou</au><au>Sato, Shigeru</au><au>Morita, Michio</au><au>Kidokoro, Minoru</au><au>Sugimoto, Masanobu</au><au>Funahashi, Shin-ichi</au><au>Osame, Mitsuhiro</au><au>Shida, Hisatoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells</atitle><jtitle>International immunology</jtitle><addtitle>Int Immunol</addtitle><date>1991-08-01</date><risdate>1991</risdate><volume>3</volume><issue>8</issue><spage>761</spage><epage>767</epage><pages>761-767</pages><issn>0953-8178</issn><eissn>1460-2377</eissn><abstract>We established long-term cell lines of cytotoxic T lymphocytes (CTL) specific for human T cell leukemia virus type I (HTLV-I) from peripheral blood lymphocytes (PBL) of a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an HTLV-l-carrler with Sjögren syndrome, and an asymptomatic HTLV-l-carrier, by repeated stimulation with autologous HTLV-I-Infected T cells In vitro. CTL derived from the patient with HAM/TSP expressed CD8 antigen, and their function was restricted by HLA-A2. They showed cytotoxic effects predominantly against the target cells expressing HTLV-I p40tax among the autologous B cell lines Infected with vaccinia recombinants containing various HTLV-I genes which served as targets. These data are consistent with the previously reported findings that fresh PBL of HAM/TSP patients contain p40tax-specific CTL activity. Furthermore, CTL derived from the patient with Sjögren syndrome without neurological involvement also demonstrated cytotoxicity predominantly to p40tax. The cytotoxicity to the target cells experimentally expressing p40tax was blocked by unlabeled HTLV-I-infected cells possessing HLA-A2. HTLV-l-specific cytotoxicity was also Inhibited by unlabeled B cells bearing p40tax. Thus, HTLV-I p40tax-specific cytotoxicity is mediated by the major CTL population activated by native HTLV-I antigens in patients with HAM/TSP or Sjögren syndrome. In contrast to the CTL of these patients, CTL similarly Induced from the asymptomatic HTLV-l-carrier, which were highly cytotoxic to autologous HTLV-l-infected T cells, did not show significant levels of cytotoxicity to autologous B cells expressing p40tax. These CTL possessed CD4 antigen. It was concluded that the predominant CTL population activated by HTLV-I stimulation differs in phenotype and antigen-specificity among HTLV-I seropositive individuals, and that these differences in CTL response may play a role in determining the susceptibility of the host to various HTLV-I related disorders.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>1911545</pmid><doi>10.1093/intimm/3.8.761</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0953-8178
ispartof International immunology, 1991-08, Vol.3 (8), p.761-767
issn 0953-8178
1460-2377
language eng
recordid cdi_proquest_miscellaneous_72107903
source MEDLINE; Oxford University Press Journals Digital Archive Legacy
subjects Adult
AIDS/HIV
B-Lymphocytes - immunology
CD8 Antigens - analysis
Cell Line
class I major histocompatibility complex
Female
Gene Products, tax - immunology
HLA-A2 Antigen - immunology
HTLV-I Infections - immunology
HTLV-I-associated myelopathy
Humans
p40tax
Paraparesis, Tropical Spastic - immunology
Phenotype
recombinant vaccinia virus
T-Lymphocytes, Cytotoxic - immunology
title Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T06%3A11%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predominant%20recognition%20of%20human%20T%20cell%20leukemia%20virus%20type%20I%20(HTLV-I)%20pX%20gene%20products%20by%20human%20CD8+%20cytotoxic%20T%20cells%20directed%20against%20HTLV-I-infected%20cells&rft.jtitle=International%20immunology&rft.au=Kannagi,%20Mari&rft.date=1991-08-01&rft.volume=3&rft.issue=8&rft.spage=761&rft.epage=767&rft.pages=761-767&rft.issn=0953-8178&rft.eissn=1460-2377&rft_id=info:doi/10.1093/intimm/3.8.761&rft_dat=%3Cproquest_cross%3E72107903%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72107903&rft_id=info:pmid/1911545&rfr_iscdi=true